A Real-world Study on Golidocitinib-based Therapeutic Regimens for the Treatment of Patients With Peripheral T-cell Lymphoma
Clinical trial NCT06963632 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06963632
- Sponsor
- Ruijin Hospital
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-04-30
- Primary completion
- 2026-12-31
- Enrollment
- 1000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.